BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/13/2016 9:14:00 AM | Browse: 983 | Download: 1450
 |
Received |
|
2016-03-15 17:24 |
 |
Peer-Review Started |
|
2016-03-18 11:19 |
 |
To Make the First Decision |
|
2016-03-31 09:52 |
 |
Return for Revision |
|
2016-04-01 14:25 |
 |
Revised |
|
2016-04-08 13:56 |
 |
Second Decision |
|
2016-04-28 09:28 |
 |
Accepted by Journal Editor-in-Chief |
|
2016-04-28 12:37 |
 |
Accepted by Executive Editor-in-Chief |
|
2016-05-04 18:40 |
 |
Articles in Press |
|
2016-05-04 18:40 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2016-05-25 18:43 |
 |
Publish the Manuscript Online |
|
2016-06-13 09:14 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
|
Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Meta-Analysis |
Article Title |
Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Lien-Chieh Lin, Tzu-Herng Hsu, Kuang-Wei Huang and Ka-Wai Tam |
Funding Agency and Grant Number |
|
Corresponding Author |
Ka-Wai Tam, MD, PhD, Center for Evidence-based Health Care, Shuang Ho Hospital, Taipei Medical University, 291, Zhongzheng Road, Zhonghe District, New Taipei 23561, Taiwan. kelvintam@h.tmu.edu.tw
|
Key Words |
Helicobacter pylori eradication; Nonbismuth concomitant quadruple therapy; Peptic ulcer; Chinese region |
Core Tip |
Helicobacter pylori (H. pylori) infection is highly prevalent in Chinese regions and associated with peptic ulcers. Currently, triple and sequential therapies have been widely used to eradicate H. pylori. Nonbismuth concomitant quadruple therapy is an alternative treatment with high efficacy. Our meta-analysis revealed that a higher H. pylori eradication rate was achieved with 7-d concomitant therapy than with 7-d triple therapy. The eradication rates of concomitant and sequential therapies were similar. However, the compliance with concomitant therapy was higher. Therefore, nonbismuth concomitant quadruple therapy should be the first-line treatment for H. pylori infection.
|
Publish Date |
2016-06-13 09:14 |
Citation |
Lin LC, Hsu TH, Huang KW, Tam KW. Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials. World J Gastroenterol 2016; 22(23): 5445-5453 |
URL |
http://www.wjgnet.com/1007-9327/full/v22/i23/5445.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v22.i23.5445 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345